Professor Terry Nolan is Redmond Barry Distinguished Professor at the University of Melbourne, and head of the Vaccine and Immunisation Research Group (or VIRGo) at the Peter Doherty Institute for Infection and Immunity and the Murdoch Children’s Research Institute. He was the Foundation Head of the Melbourne University School of Population and Global Health between 2001 and 2019.

Prof. Nolan is a pediatrician and clinical epidemiologist, graduated in medicine and in medical science from the University of Western Australia, trained in paediatrics at the Royal Children's Hospital in Melbourne and at the Montréal Children's Hospital, and was awarded a PhD in in epidemiology and biostatistics from McGill University in Montréal. 

His expertise relates to immunisation, pandemic vaccine planning and response, and clinical trials of new vaccines. He has authored more than 250 publications in scientific journals. He has provided advice and expertise to many of the world’s leading vaccine manufacturers and their scientists on the development and testing of dozens of new vaccines.

He is part of a Doherty Institute-Monash University team developing two ‘next generation’ SARS-CoV-2 receptor binding domain (RBD) vaccine candidates (adjuvanted recombinant protein and an mRNA lipid nanoparticle) targeting a variant strain of the virus. He leads the Phase I study of these vaccines, now fully recruited in Melbourne.

He was Chair of the Australian Technical Advisory Group on Immunisation (ATAGI) for a decade. He is a Fellow of the Australian Academy of Health and Medical Sciences, and a former member of SAGE, the World Health Organization’s main advisory group on vaccines and Immunisation.